Literature DB >> 17629470

Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

Ricard Pifarre1, Miquel Falguera, Carmina Vicente-de-Vera, Antonio Nogues.   

Abstract

STUDY
OBJECTIVES: Community-acquired pneumonia is a frequent event in the course of chronic obstructive pulmonary disease (COPD). The aim of the present study was to provide information on clinical and microbiological characteristics and outcome of community-acquired pneumonia in these patients, in a comparative study with the non-COPD population.
DESIGN: Prospective study of cases.
SETTING: A university hospital in Lleida, Spain. PATIENTS: During a 6 year-period, we prospectively studied the clinical and radiological manifestations, microbiological data and outcome of all patients with community-acquired pneumonia. A comparative analysis of characteristics of pneumonia between 132 patients with a definitive diagnosis of COPD and 575 patients who did not have this underlying disease was performed. MEASUREMENTS AND
RESULTS: COPD was associated with an older and predominantly male population. These patients frequently had concomitant comorbidities such as diabetes mellitus or chronic heart failure. Clinical presentation was more severe, manifested by septic shock, tachypnea, lower values of pH, pO(2) and oxygen saturation, and greater values of pCO(2). Purulent expectoration was also more frequent in this subset of patients. Admission was usually required for patients with COPD, and length of hospitalization was significantly increased; however, difference in the mortality rate was not observed. Although the spectrum of responsible microorganisms was very similar, the incidence of Pseudomonas aeruginosa and other Gram-negative bacilli was increased in COPD, particularly among patients with advanced situation and/or oral corticosteroid treatment.
CONCLUSIONS: Community-acquired pneumonia in patients with COPD was associated with epidemiological and clinical particularities mainly related to the underlying disease but showed only minor differences in outcome parameters. Gram-negative bacilli and P. aeruginosa are potential pathogens that need to be considered.

Entities:  

Mesh:

Year:  2007        PMID: 17629470     DOI: 10.1016/j.rmed.2007.05.011

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  21 in total

1.  Identification of bacterial pathogens in pediatric community-acquired lower respiratory tract infection using a simplified procedure of sputum sampling and examination: comparison between hospitalized children with and without underlying diseases.

Authors:  T Hoshina; K Kusuhara; T Takimoto; M Saito; T Hara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-24       Impact factor: 3.267

2.  The Eating Assessment Tool-10 Predicts Aspiration in Adults with Stable Chronic Obstructive Pulmonary Disease.

Authors:  Julie Regan; Susan Lawson; Vânia De Aguiar
Journal:  Dysphagia       Date:  2017-07-13       Impact factor: 3.438

3.  Increased Severity and Mortality of CAP in COPD: Results from the German Competence Network, CAPNETZ.

Authors:  Dionne C W Braeken; Frits M E Franssen; Hartwig Schütte; Mathias W Pletz; Robert Bals; Peter Martus; Gernot G U Rohde
Journal:  Chronic Obstr Pulm Dis       Date:  2015-03-26

4.  Community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

Authors:  Aykut Cilli
Journal:  Curr Infect Dis Rep       Date:  2015-01       Impact factor: 3.725

Review 5.  Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality.

Authors:  T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

6.  Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: How Significant is the Risk of Pneumonia and Should It Impact Use of Inhaled Corticosteroids?

Authors:  Rodrigo Cavallazzi; Sonal Singh
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 7.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

8.  COPD patients with ventilator-associated pneumonia: implications for management.

Authors:  D Koulenti; S Blot; J M Dulhunty; L Papazian; I Martin-Loeches; G Dimopoulos; C Brun-Buisson; M Nauwynck; C Putensen; J Sole-Violan; A Armaganidis; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-25       Impact factor: 3.267

9.  Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected.

Authors:  E Calbo; E Valdés; A Ochoa de Echagüen; A Fleites; L Molinos; M Xercavins; N Freixas; M Rodríguez-Carballeira; J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-10       Impact factor: 3.267

10.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.